© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Beyond Air, Inc. (XAIR) stock remained unchanged at $1.08 a share on NASDAQ. The stock opened at $1.05, fluctuating between $1.03 to $1.17 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 18, 2026 | 1.11 | 1.16 | 1.03 | 1.08 | 231.31K |
| Feb 17, 2026 | 1.14 | 1.14 | 1.00 | 1.08 | 602.39K |
| Feb 13, 2026 | 1.05 | 1.15 | 1.00 | 1.05 | 569.37K |
| Feb 12, 2026 | 1.07 | 1.08 | 0.95 | 1.02 | 344.09K |
| Feb 11, 2026 | 1.11 | 1.11 | 1.03 | 1.04 | 270.99K |
| Feb 10, 2026 | 1.16 | 1.16 | 1.08 | 1.08 | 221.71K |
| Feb 09, 2026 | 1.18 | 1.25 | 1.14 | 1.16 | 335.2K |
| Feb 06, 2026 | 1.08 | 1.15 | 1.06 | 1.15 | 328.95K |
| Feb 05, 2026 | 1.09 | 1.09 | 1.03 | 1.05 | 179.13K |
| Feb 04, 2026 | 1.15 | 1.15 | 1.03 | 1.09 | 167.99K |
| Feb 03, 2026 | 1.16 | 1.23 | 1.09 | 1.15 | 479.35K |
| Feb 02, 2026 | 1.16 | 1.24 | 1.13 | 1.15 | 213.12K |
| Jan 30, 2026 | 1.24 | 1.27 | 1.17 | 1.19 | 321.23K |
| Jan 29, 2026 | 1.26 | 1.35 | 1.22 | 1.23 | 355.14K |
| Jan 28, 2026 | 1.40 | 1.40 | 1.26 | 1.27 | 356.69K |
| Jan 27, 2026 | 1.46 | 1.56 | 1.31 | 1.35 | 642.76K |
| Jan 26, 2026 | 1.66 | 1.66 | 1.45 | 1.46 | 396.31K |
| Jan 23, 2026 | 1.77 | 1.78 | 1.59 | 1.62 | 695.39K |
| Jan 22, 2026 | 1.83 | 1.89 | 1.72 | 1.77 | 730.94K |
| Jan 21, 2026 | 1.91 | 2.00 | 1.75 | 1.82 | 1.32M |
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
| Employees | 107 |
| Beta | 0.39 |
| Sales or Revenue | $3.71M |
| 5Y Sales Change% | -0.547% |
| Fiscal Year Ends | March |
| Sector | Healthcare |
| Industry | Medical - Devices |